Receiving a vial is a small event with a large audit footprint. Before an external quality-system inspection, the question is rarely whether the vial is on a shelf; it is whether the laboratory can show how it arrived, what it is, where it is stored, who may handle it and which document supports the batch identity. A COSHH-aware inventory gives that chain a fixed structure. It also keeps the research-use-only status visible at the point of use. The material is not for human or veterinary use, and every record should reinforce that boundary.
Build the Receiving Record Before the Vial Reaches the Shelf
The inventory entry should begin at the purchase request, not when the courier hands over the parcel. Capture the supplier name exactly as it appears on the order confirmation, the catalogue item and SKU, the number of containers, the order reference, the intended in-vitro study or analytical work, the stated storage requirement and the location of the batch CoA. Add a field for the research-use-only statement. This is not paperwork for its own sake: an inspector may follow the vial from procurement to disposal, and an incomplete receiving record forces staff to reconstruct the story from emails and memory.
At receipt, inspect the packaging and label before placing the vial in storage. Record the condition of the outer packaging, the label reference, the quantity received and the storage location. Vial labels described by the supplier use a reference format that combines the SKU code and expiry month/year, which links to the corresponding CoA; quote that reference when contacting the supplier about documentation. Do not use cap colour as an indicator of identity, analytical quality or manufacturing origin. Packaging can vary between deliveries, and a restocked item may carry the same Internal Test Reference as earlier stock; that reference links to associated sample testing reports, but it does not confirm that separate deliveries come from the same production lot or have had separate independent testing.
For records built from a live catalogue, the supplier field should mirror the order confirmation. If the research team found the material through a UK-facing listing such as Peptide uk, the inventory should still carry the full trading name and order reference rather than a shortened label. Keep the order confirmation, dispatch note and CoA together in the batch file. If the CoA is not yet available, mark the vial as pending documentation and do not allow it to drift into general laboratory use until the record is complete. The same receiving record should state clearly that materials are not for human or veterinary use.
Map the Vial to a COSHH-Aware Record, Not Just a Stock Line
A stock line usually records name, quantity and location. A COSHH-aware entry goes further. It should link the vial to the local risk assessment, the authorised handler list, the storage conditions, the physical form, the waste or disposal route and the emergency arrangements for the area. Where a formal hazard classification is not present in the supplied documentation, do not invent one; mark the field as “not assessed” and route the record to the person responsible for health and safety. The inventory is a signpost to controlled handling, not a substitute for a COSHH assessment.
Storage fields should reflect the supplier’s published handling guidance for the specific item. Lyophilised research peptides are typically described as requiring storage at –20°C or below, sealed with desiccant and protected from moisture, heat and light, with avoidance of repeated freeze–thaw cycles; after reconstitution in an in-vitro laboratory workflow, short-term storage at 2–8°C is described. The supplier also notes that peptides contain trace amounts of mannitol as an excipient. Treat those as handling details to verify against the batch label and CoA, not as universal rules for every material. Record the freezer, shelf or container position so that a physical count can be reconciled later.
Handling information should stay inside the laboratory workflow. Allow vials to reach room temperature before opening, work in a clean environment and remove only the amount required for the experiment. If reconstitution is part of an in-vitro assay, record the diluent volume and the concentration prepared for that assay, label the secondary container and keep the calculation with the experimental record. The supplier’s free reconstitution calculator is a laboratory research tool only; it must not be used for human or veterinary dosing. The same restriction applies to the materials themselves: they are not for human or veterinary use, consumption, administration or clinical application.
Reconcile Documentation and Audit Trails Before the Inspector Calls
Ahead of an external quality-system inspection, run a short reconciliation exercise rather than a last-minute search. Select a sample of UK-sourced vials and follow each one from inventory entry to physical location and CoA. Check that the label reference, SKU and batch file agree. Open the actual CoA that accompanies the batch and confirm that the document relates to that batch; do not rely on a generic product page, an old certificate or a remembered purity statement. Where the live site publishes headline figures or testing statements, treat them as the supplier’s current published wording and reconfirm them against the batch document and the live page before repeating them in an inspection file.
Restocks deserve particular attention. The supplier’s FAQ position is that an Internal Test Reference links to associated sample testing reports but does not establish that separate deliveries are the same production lot or that each delivery has had separate independent testing. Record the order reference alongside the CoA and note any packaging variation without drawing quality conclusions from it. If the homepage lists “CoAs Janoshik Analytical Reports”, open and check the specific batch CoA rather than assuming that a named report applies to every vial. Missing or mismatched documents should go into a gap log with an owner and a corrective action, not into a folder labelled “to sort later”.
Finally, test whether staff can explain the record without prompting. Ask an authorised handler to locate the CoA, describe the storage location, identify the risk assessment link and state why the material is restricted to controlled laboratory and analytical research. The answer should be consistent with the inventory entry and the label. When the CoA, label and inventory record agree, the vial has a traceable identity; when they do not, the discrepancy becomes the audit finding. That is the practical difference between holding a UK-sourced vial and holding an inspection-ready record.
Hailing from Valparaíso, Chile and currently living in Vancouver, Teo is a former marine-biologist-turned-freelance storyteller. He’s penned think-pieces on deep-sea drones, quick-fire guides to UX design, and poetic musings on street food culture. When not at the keyboard, he’s scuba-diving or perfecting his sourdough. Teo believes every topic has a hidden tide waiting to be charted.